Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-07-30Clinical Trial Update: Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY. [Phase 2, Phase 3]
Update on the TRACIA trial evaluating intracoronary autologous stem cell transplantation for acute myocardial infarction, currently in Phase…
-
FDA approval · 2008-07-24FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for Lopressor (metoprolol tartrate) from Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHS
Completed ancillary study to the Cardiovascular Health Study examining molecular epidemiology of myocardial infarction and stroke in older a…
-
CLINICAL_TRIALS trial_result · 2008-07-08Clinical Trial Update: Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein [Phase 3]
A Phase 3 trial evaluating whether N-acetylcysteine can improve myocardial salvage and reduce contrast-induced nephropathy in myocardial inf…
-
FDA approval · 2008-06-20FDA Approved: RAMIPRIL — Original Application (GSMS, Incorporated)
FDA approved RAMIPRIL as a generic drug under an original Abbreviated New Drug Application (ANDA 079116) filed by GSMS, Incorporated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Telmisartan Versus Ramipril After Acute Coronary Syndrome [Phase 4]
A Phase 4 clinical trial comparing telmisartan to ramipril in patients after acute coronary syndrome to evaluate outcomes; the current statu…
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure [Phase 4]
Phase 4 trial evaluating whether N-3 fatty acids can prevent atrial fibrillation in patients with acute heart failure.
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for ramipril, authorizing the marketing of a generic ramipril product.
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Chartwell RX, LLC.)
The FDA approved Chartwell RX, LLC's original generic application for ramipril, enabling the marketing of a RAMIPRIL product.
-
CLINICAL_TRIALS trial_result · 2008-06-10Clinical Trial Update: The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia [NA]
This completed clinical trial examined whether GLP-1 affects glucose uptake in the brain and heart during hypoglycemia in healthy men.
-
CLINICAL_TRIALS trial_result · 2008-06-06Clinical Trial Update: Letigen® and Cardiovascular Morbidity
A completed clinical trial evaluating Letigen® for cardiovascular morbidity has been reported. The study focused on outcomes including strok…
-
CLINICAL_TRIALS trial_result · 2008-05-30Clinical Trial Update: Troponin-T for Detection of Perioperative Cardiovascular Events
A completed clinical trial evaluating troponin-T as a biomarker for detecting perioperative cardiovascular events, including myocardial infa…
-
EMA withdrawal · 2008-05-27EMA Application withdrawn: DuoCover (clopidogrel;acetylsalicylic acid) — Bristol Myers Squibb Pharma EEIG
EMA withdrew the application for DuoCover (clopidogrel and acetylsalicylic acid) from Bristol Myers Squibb Pharma EEIG.
-
EMA withdrawal · 2008-05-27EMA Application withdrawn: DuoPlavin (clopidogrel;acetylsalicylic acid) — Sanofi Pharma Bristol-Myers Squibb
EMA withdrew the application for DuoPlavin (clopidogrel and acetylsalicylic acid) by Sanofi Pharma Bristol-Myers Squibb.
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Stem Cell Therapy to Improve Myocardial Function in Patients With Acute Myocardial Infarction [NA]
This clinical trial update notes that a study evaluating stem cell therapy to improve myocardial function in patients with acute myocardial …
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours [Phase 2]
Phase 2 clinical trial evaluating primary angioplasty for acute myocardial infarction in patients with symptom duration over 12 hours has co…
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Efficacy and Safety of Prehospital Administration of Bivalirudin in STEMI Patients
Results from a completed trial evaluating the efficacy and safety of prehospital administration of bivalirudin in STEMI patients were report…
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Myocardial Infarction Size Reduction With Atorvastatin [Phase 4]
Phase 4 trial update evaluating whether atorvastatin reduces myocardial infarct size and reperfusion injury.
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: Safety of TG100-115 for Heart Attack Treated With Angioplasty [Phase 1, Phase 2]
This document reports on the safety findings from Phase 1/2 trials of the investigational compound TG100-115 in patients with myocardial inf…
-
EMA withdrawal · 2008-05-16EMA Withdrawn: Quixidar (fondaparinux sodium) — Glaxo Group Ltd.
The EMA indicates withdrawal of Quixidar (fondaparinux sodium) from the market by Glaxo Group Ltd., covering indications including venous th…
-
CLINICAL_TRIALS trial_result · 2008-05-16Clinical Trial Update: Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization [Phase 2]
Phase 2 pilot study of hemoglobin-based oxygen therapeutics in elective coronary revascularization has completed, evaluating safety and pote…
-
FDA approval · 2008-05-13FDA Approved: TNKASE — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for TNKASE (tenecteplase) filed by Genentech, Inc., enabling changes to the product's labeling a…
-
FDA approval · 2008-04-29FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC.
-
FDA approval · 2008-04-23FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for enalapril maleate (a generic ACE inhibitor) by Heritage Pharmaceuticals (d/b/a Avet Pharmace…
-
CLINICAL_TRIALS trial_result · 2008-04-21Clinical Trial Update: Warfarin After Anterior ST-Elevation Myocardial Infarction [NA]
This entry notes that a clinical trial evaluating the use of warfarin after anterior ST-elevation myocardial infarction has completed.